0001127602-21-010812.txt : 20210316 0001127602-21-010812.hdr.sgml : 20210316 20210316163759 ACCESSION NUMBER: 0001127602-21-010812 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180315 FILED AS OF DATE: 20210316 DATE AS OF CHANGE: 20210316 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: EDGEMOND JAMES CENTRAL INDEX KEY: 0001636178 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-26301 FILM NUMBER: 21746353 MAIL ADDRESS: STREET 1: 1040 SPRING STREET CITY: SILVER SPRING STATE: MD ZIP: 20910 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: UNITED THERAPEUTICS Corp CENTRAL INDEX KEY: 0001082554 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 521984749 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1040 SPRING ST CITY: SILVER SPRING STATE: MD ZIP: 20910 BUSINESS PHONE: 3016089292 MAIL ADDRESS: STREET 1: 1040 SPRING ST CITY: SILVER SPRING STATE: MD ZIP: 20910 FORMER COMPANY: FORMER CONFORMED NAME: UNITED THERAPEUTICS CORP DATE OF NAME CHANGE: 19990324 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2018-03-15 0001082554 UNITED THERAPEUTICS Corp UTHR 0001636178 EDGEMOND JAMES 1040 SPRING STREET SILVER SPRING MD 20910 1 CFO and Treasurer Common Stock 1229 D Stock Options 111.00 2018-03-15 4 A 0 75349 0 A 2021-03-15 2018-03-15 Common Stock 75349 75349 D Includes 156 shares acquired on March 4, 2021 under the United Therapeutics Corporation Employee Stock Purchase Plan. These performance-based stock options were initially awarded on March 15, 2018, subject to a three-year performance condition tied to average cash profit margin during 2018-2020, which was determined on February 24, 2021. Number of stock options reported represents the number of options earned based on performance. /s/ John S. Hess, Jr. under Power of Attorney 2021-03-16